ArticleESMO real world data and digital oncology2026
Development and evaluation of a large language model-based, retrieval-augmented generation application for query response in early oncology clinical trials.
Article in ESMO real world data and digital oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early-phase oncology trials involve complex protocols and extensive documents, making timely resolution of study queries challenging. We developed the Study Document Assistant (SDA), a retrieval-augmented generation (RAG) system that integrates semantic search with large language models to generate context-specific answers from clinical trial documentation. Materials and methods: SDA processes study documents and delivers responses through a secure, conversational interface. A two-arm experiment was conducted in which sponsor clinical study team members answered protocol-related queries either with or without SDA. Questions were stratified by difficulty and assessed by blinded subject matter experts (SMEs) and artificial intelligence (AI) models. The primary endpoint was mean response time. Main secondary endpoints included response time as a time-to-event outcome and overall accuracy. SDA user satisfaction was also assessed. Data were analyzed using Welch Results: In the experiment ( Conclusions: Our findings demonstrate that SDA accelerates query resolution without compromising answer quality, highlighting the potential of RAG-based digital assistants to streamline clinical trial operations and enhance research efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.